Carisma Therapeutics Inc (CARM) Return on Investment ROI from the third quarter of 2025 to third quarter of 2024 and for the year 2025, average high and low, overall ranking from Sep 30 2025 to Sep 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Carisma Therapeutics Inc   (NASDAQ: CARM)


Carisma Therapeutics Inc's ROI from its third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Carisma Therapeutics Inc's ROI in the third quarter of 2025?
Carisma Therapeutics Inc achieved a return on average invested assets (ROI) of 1948.98 % in its third quarter of 2025 a new company high.

ROI has improved compared to -322.53% in the second quarter of 2025, due to net income growth.

Within the Healthcare sector only one company had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2025 quarter, so far to 13, from total ROI ranking in the second quarter of 2025 at 3898.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Investment Change TTM -92.5 % -82.54 % -72.28 % -63.98 % 0.54 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 0 -4 6 14 32
Return On Investment (TTM) - - -172.62 % -160.97 % -200.51 %
CARM's Overall Ranking # 13 # 3898 # 3170 # 3655 # 4109
Seq. Investment Change TTM -66.9 % -50.1 % -36.7 % -28.28 % -22.93 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 77 -38 -41 -60 -105

CARM Company Profile >> Back to CARM Roi Comparisons >> See Annual CARM Return On Investment



Return On Investment CARM's Ranking
Within: No.
Industry # 2
Sector # 2
Overall # 13

Return On Investment Statistics
High Average Low
1948.98 %
-7.17 %
-322.53 %
(Sep 30 2025)   (Jun 30 2025)







Financial Statements
Carisma Therapeutics Inc's III. Quarter Investments $ 0 Millions CARM's Balance sheet
Carisma Therapeutics Inc's III. Quarter Income $ 89 Millions Quarterly CARM's Income Statement
CARM's Income by Division See CARM's Income by Division


CARM Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 14 74 158 229 105
Y / Y Investment Growth -80.44 % -53.44 % -30.98 % 118.74 % 12.27 %
Net Income in Millions -60 -87 4 8 -2
Y / Y Net Income Growth - - -53.16 % - -
Annual Return On Investment -419.89 % -117.97 % 2.45 % 3.61 % -1.52 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CARM's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CARM's Competitors
Subscribers only: Roi for Carisma Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for CARM's Customers

Other Ratios
CARM's Roa CARM's Inventory Turnover Ratio CARM's Growth Rates CARM's Dividend Statistics
CARM's Profitability Ratios CARM's Asset Turnover Ratio CARM's Dividend Growth
CARM's Roe CARM's Valuation Ratios CARM's Financial Strength Ratios CARM's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2025, within Healthcare Sector ROI
Carisma Therapeutics Inc   1,948.98 %
Glucotrack Inc   460.92 %
Atara Biotherapeutics Inc   404.88 %

Date modified: 2026-09-26T06:59:14+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.